Back to Search Start Over

Radioimmunoassays of Ethinyl-norgestrienone (R-2323) and medroxyprogesterone acetate (MPA) and their clinical applicability.

Authors :
Frick, J.
Bartsch, G.
Jakse, G.
Source :
Urological Research; Jun1977, Vol. 5 Issue 2, p55-59, 5p
Publication Year :
1977

Abstract

Radioimmunoassays for 2 synthetic progestins (Ethinyl-norgestrienone, R 2323 and medroxyprogesterone acetate, MPA) are demonstrated. 10 patients aged 31 to 72 years were treated with ethinyl-norgestrienone with different schedules and 3 men suffering from benign prostatic hypertrophy were treated with medroxyprogesterone acetate. Plasma levels of testosterone, LH, FSH were monitored before, during and after treatment. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
03005623
Volume :
5
Issue :
2
Database :
Complementary Index
Journal :
Urological Research
Publication Type :
Academic Journal
Accession number :
70764515
Full Text :
https://doi.org/10.1007/BF00256842